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ANTIEPILEPTIC DRUGS
Epilepsy
A group of chronic CNS disorders characterized by 
recurrent seizures.
• Seizures are sudden, transitory, and uncontrolled 
episodes of brain dysfunction resulting from abnormal 
discharge of neuronal cells with associated motor, 
sensory or behavioral changes.
Causes for Acute Seizures
• Trauma
• Encephalitis
• Drugs
• Birth trauma
• Withdrawal from 
depressants
• Tumor
• High fever
• Hypoglycemia
• Extreme acidosis
• Extreme alkalosis
• Hyponatremia
• Hypocalcemia
• Idiopathic
Seizures
• The causes for seizures can be multiple, from infection, 
to neoplasms, to head injury.  In a few subgroups it is an 
inherited disorder.
• Febrile seizures or seizures caused by meningitis are 
treated by antiepileptic drugs, although they are not 
considered epilepsy (unless they develop into chronic 
seizures).
• Seizures may also be caused by acute underlying toxic 
or metabolic disorders, in which case the therapy should 
be directed towards the specific abnormality.
Neuronal Substrates of Epilepsy
The Brain
The Synapse
The Ion Channels/Receptors
ions
I. Partial (focal) Seizures
A. Simple Partial Seizures
B. Complex Partial Seizures
II. Generalized Seizures
A. Generalized Tonic-Clonic Seizures
B. Absence Seizures
C. Tonic Seizures
D. Atonic Seizures
E. Clonic Seizures
F. Myoclonic Seizures
G. Infantile Spasms
Classification of Epileptic Seizures

I. Partial (Focal) Seizures
A. Simple Partial Seizures
B. Complex Partial Seizures.
A. Simple Partial Seizures (Jacksonian)
• Involves one side of the brain at onset.
• Focal w/motor, sensory or speech disturbances.
• Confined to a single limb or muscle group.
• Seizure-symptoms don’t change during 
seizure.
• No alteration of consciousness.
EEG: Excessive synchronized discharge by a small 
group of neurons. Contralateral discharge.
I. Partial (Focal) Seizures
B. Complex Partial Seizures (Temporal Lobe 
epilepsy or Psychomotor Seizures)
• Produces confusion and inappropriate or dazed 
behavior.
• Motor activity appears as non-reflex actions. 
Automatisms (repetitive coordinated movements).
• Wide variety of clinical manifestations.
• Consciousness is impaired or lost.
EEG: Bizarre generalized EEG activity with evidence 
of anterior temporal lobe focal abnormalities. 
Bilateral.
I. Partial (focal) Seizures
II. Generalized Seizures
A. Generalized Tonic-Clonic 
Seizures
B. Absence Seizures
C. Tonic Seizures
D. Atonic Seizures
E. Clonic Seizures
F. Myoclonic Seizures.
G. Infantile Spasms
II. Generalized Seizures
In Generalized seizures, 
both hemispheres are 
widely involved 
from the outset. 
Manifestations of the 
seizure are 
determined by the 
cortical site at which 
the seizure arises.  
Present in 40% of all 
epileptic Syndromes.
II. Generalized Seizures
A. Generalized Tonic-Clonic Seizures 
Major convulsions, usually with two phases:
1)  Tonic phase
2)  Clonic phase
Convulsions:  
– motor manifestations
– may or may not be present during seizures
– excessive neuronal discharge
Convulsions appear in Simple Partial and Complex Partial 
Seizures if the focal neuronal discharge includes motor 
centers; they occur in all Generalized Tonic-Clonic Seizures 
regardless of the site of origin. 
Atonic, Akinetic, and Absence Seizures are non-convulsive 
Scheme of Seizure Spread
Generalized Tonic-Clonic Seizures
Both hemispheres are
involved from outset 
B. Absence Seizures (Petite Mal)
• Brief and abrupt loss of consciousness, vacant 
stare.
• Sometimes with no motor manifestations.
• Minor muscular twitching restricted to eyelids 
(eyelid flutter) and face. 
• Typical 2.5 – 3.5 Hz spike-and-wave 
discharge.
• Usually of short duration (5-10 sec), but may 
occur dozens of times a day.
• No loss of postural control.
II. Generalized Seizures
B. Absence Seizures (con’t)
• Often begin during childhood (daydreaming attitude, 
no participation, lack of concentration).
• A low threshold Ca2+ current has been found to 
govern oscillatory responses in thalamic neurons 
(pacemaker) and it is probably involve in the 
generation of these types of seizures.   
EEG: Bilaterally synchronous, high voltage 3-per-second spike-
and-wave discharge pattern.
Spike-wave phase:
Neurons generate short duration depolarization and a 
burst of action potentials, but there is no sustained 
depolarization or repetitive firing of action potentials.
II. Generalized Seizures
Scheme of Seizure Spread
Primary Generalized
Absence Seizures
Thalamocortial
relays are believed 
to act on a 
hyperexcitable
cortex
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II. Generalized Seizure
C. Tonic Seizures
• Opisthotonus, loss of consciousness.
• Marked autonomic manifestations
D. Atonic Seizures (atypical)
• Loss of postural tone, with sagging of the 
head or falling.
• May loose consciousness.
II. Generalized Seizure
E. Clonic Seizures
• Clonic Seizures: Rhythmic clonic contractions 
of all muscles, loss of consciousness, and 
marked autonomic manifestations.
F. Myoclonic Seizures
• Myoclonic Seizures: Isolated clonic jerks 
associated with brief bursts of multiple spikes 
in the EEG.
II. Generalized Seizures
F.    Infantile Spasms
• An epileptic syndrome.
• Attacks, although fragmentary, are often 
bilateral.
• Characterized by brief recurrent myoclonic
jerks of the body with sudden flexion or 
extension of the body and limbs.
Treatment of Seizures
Treatment of Seizures
Goals:
• Block repetitive neuronal firing.
• Block synchronization of neuronal 
discharges.
• Block propagation of seizure.
Minimize side effects with the simplest drug 
regimen.
MONOTHERAPY IS RECOMMENDED IN MOST CASES
Treatment of Seizures
Strategies:
• Modification of ion conductances. 
• Increase inhibitory (GABAergic) transmission.
• Decrease excitatory (glutamatergic) activity.
Antiseizure drugs
Mechanisms of action
1. Inhibit glutamate neurotransmission
Felbamate, topiramate and valproate
1. Enhancement of GABA actions
-increase GABA actions at receptor 
(benzodiazepines, phenobarbital)
-vigabatrin inhibits GABA transaminase
-tiagabin blocks GABA uptake
2. Inhibition of sodium channel function
-phenytoin, carbamazepine, valproic acid, 
lamotrigine
3. Inhibition of Calcium T-type channels (ethosuximide)
GABAergic SYNAPSE
Drugs that Act at the 
GABAergic Synapse
• GABA agonists
• GABA antagonists
• Barbiturates
• Benzodiazepines
• GABA uptake inhibitors
Goal : GABA Activity
GLUTAMATERGIC SYNAPSE
• Excitatory Synapse.
• Permeable to Na+, Ca2+ and 
K+.
• Magnesium ions block 
channel in resting state.
• Glycine (GLY) binding 
enhances the ability of GLU 
or NMDA to open the 
channel.
• Agonists: NMDA, AMPA, 
Kianate.
Goal: GLU Activity
Mg++
Na+
AGONISTS
GLU
Ca2+
K+
GLY
Treatment of Seizures
1) Hydantoins: phenytoin
2) Barbiturates: phenobarbital
3) Oxazolidinediones: trimethadione
4) Succinimides: ethosuximide
5) Acetylureas: phenacemide
6) Other: carbamazepine, lamotrigine, 
vigabatrin, etc.
7) Diet
8) Surgery, Vagus Nerve Stimulation (VNS).
Treatment of Seizures
PARTIAL SEIZURES ( Simple and Complex,  
including secondarily generalized)
Drugs of choice: Carbamazepine
Phenytoin
Valproate
Alternatives: Lamotrigine,  phenobarbital, 
primidone, oxcarbamazepine.
Add-on therapy: Gabapentin, topiramate, 
tiagabine, levetiracetam, zonisamide.
Treatment of Seizures
PRIMARY GENERALIZED TONIC-CLONIC 
SEIZURES (Grand Mal)
Drugs of choice:  Carbamazepine 
Phenytoin
Valproate*
Alternatives: Lamotrigine, phenobarbital, 
topiramate, oxcartbazepine, primidone, 
levetiracetam, phenobarbital.
*Not approved except if absence seizure is involved
Drugs for Partial Seizures and 
Generalized Tonic-Clonic Seizures
•Phenytoin – preferentially binds to and prolongs the 
inactive state of voltage-sensitive Na channels
•Carbamazepine –tricyclic compound that blocks voltage-
sensitive Na channels and acts presynaptically to decrease 
synaptic transmission.
Carbamazepine induces microsomal enzymes leading to an 
increase in its own clearance after chronic use and several 
important drug interactions
•Valproate – blocks voltage-sensitive Na channels and T-
type Ca2+ channels, increases GABA synthesis, decreases 
GABA degradation, may decrease glutamate synthesis
Adjuncts in the treatment of 
Partial Seizures
• Felbamate – blocks glycine activation of NMDA 
receptors and inhibit initiation of seizures
• Gabapentin – despite the fact that Gabapentin has a 
similar structural relationship to GABA, it does not 
act on the GABA receptor.  Gabapentin may alter 
GABA metabolism or alter reuptake by presynaptic
GABA transporters.
• Lamotrigine – blocks voltage-sensitive NA channels 
and has another mechanism of action (inhibits the 
release of excitatory amino acids such as glutamate?)
• Topiramate - blocks voltage-sensitive NA channels, 
augments GABA activation of GABAA receptor, 
blocks kainate and AMPA glutamate receptors
Treatment of Seizures
GENERALIZED ABSENCE SEIZURES 
Drugs of choice: Ethosuximide 
Valproate*
Alternatives: Lamotrigine, clonazepam, 
zonisamide, topiramate (?).
* First choice if primary generalized tonic-clonic seizure is also 
present.
Treatment of Seizures
ATYPICAL ABSENCE, MYOCLONIC, 
ATONIC* SEIZURES
Drugs of choice: Valproate**
Lamotrigine***
Alternatives: Topiramate, clonazepam, 
zonisamide, felbamate.
* Often refractory to medications.
**Not approved except if absence seizure is involved.
*** Not FDA approved for this indication. 
Treatment of Seizures
INFANTILE SPASMS
Drugs of choice: Corticotropin (IM) or 
Corticosteroids (Prednisone)
Zonisamide
Alternatives: Clonazepam, nitrazepam, 
vigabatrin, phenobarbital.
Infantile Spasms
• Infantile spasms are an epileptic syndrome and not a 
seizure type.
• The attacks although sometimes fragmentary are most 
often bilateral and are included, for pragmatic 
purposes, with the generalized seizures.
• Characterized by recurrent myoclonic jerks with 
sudden flexion or extension of the body and limbs; the 
form of infantile spasms are, however, quite 
heterogeneous.
• 90% have their first attack before the age of 1 year.
• Most patients are mentally retarded, presumably from 
the same cause of the spasms.
• The cause is unknown.  Infections, kernicterus, 
tuberous sclerosis and hypoglycemia have all been 
implicated.
Drugs for Partial Seizures and 
Generalized Tonic-Clonic Seizures
•Phenytoin – preferentially binds to and prolongs the 
inactive state of voltage-sensitive Na channels
•Carbamazepine –tricyclic compound that blocks voltage-
sensitive Na channels and acts presynaptically to decrease 
synaptic transmission.
Carbamazepine induces microsomal enzymes leading to an 
increase in its own clearance after chronic use and several 
important drug interactions
•Valproate – blocks voltage-sensitive Na channels and T-
type Ca2+ channels, increases GABA synthesis, decreases 
GABA degradation, may decrease glutamate synthesis
Adjuncts in the treatment of 
Partial Seizures
• Felbamate – blocks glycine activation of NMDA 
receptors and inhibit initiation of seizures
• Gabapentin – despite the fact that Gabapentin has a 
similar structural relationship to GABA, it does not 
act on the GABA receptor.  Gabapentin may alter 
GABA metabolism or alter reuptake by presynaptic
GABA transporters.
• Lamotrigine – blocks voltage-sensitive NA channels 
and has another mechanism of action (inhibits the 
release of excitatory amino acids such as glutamate?)
• Topiramate - blocks voltage-sensitive NA channels, 
augments GABA activation of GABAA receptor, 
blocks kainate and AMPA glutamate receptors
Status Epilepticus
Status Epilepticus
Status epilepticus exists when seizures recur within 
a short period of time , such that baseline 
consciousness is not regained between the 
seizures.  They last for at least 30 minutes. Can 
lead to systemic hypoxia, acidemia, 
hyperpyrexia, cardiovascular collapse, and renal 
shutdown.
• The most common, generalized tonic-clonic status 
epilepticus is life-threatening and must be treated 
immediately with concomitant cardiovascular, 
respiratory and metabolic management.
Drugs for Status Epilepticus
• Diazepam – GABA mediated Cl- flux
• Phenytoin – voltage-sensitive Na channels
• Phenobarbital –if necessary 
• General anesthesia
DIAZEPAM (Valium) AND 
LORAZEPAM (Ativan)
• Benzodiazepines.
• Will also be discussed with 
Sedative hypnotics.
• Given I.V.
• Lorazepam may be longer acting.
• 1° for treating status epilepticus
• Have muscle relaxant activity.
• Allosteric modulators of GABA 
receptors.
• Potentiates GABA function, by 
increasing the frequency of 
channel opening.
Toxicity
•Sedation
•Children may 
manifest  a 
paradoxical 
hyperactivity.
•Tolerance
Treatment of Status Epilepticus in Adults
Initial
• Diazepam, i.v. 5-10 mg (1-2 mg/min)
repeat dose (5-10 mg) every 20-30 min.
• Lorazepam, i.v. 2-6 mg (1 mg/min) 
repeat dose (2-6 mg) every 20-30 min.
Follow-up
• Phenytoin, i.v. 15-20 mg/Kg (30-50 mg/min).
repeat dose (100-150 mg) every 30 min.
• Phenobarbital, i.v. 10-20 mg/Kg (25-30mg/min).
repeat dose (120-240 mg) every 20 min.
Status epilepticus
0-5 min history, physical examination, intubation?, ECG
5-10 min start 2 large bore IV saline, dextrose, thiamine, 
lorazepam or diazapam IV
10-30 min Phenytoin or phenobarbital IV
30-60 min If seizures persist after phenytoin, use 
phenobarbital or vice versa. Admit 
to CCU, get EEG, consider 
thiopental, propofol

Drug interactions
• Many antiepileptic drugs interact with 
other medications
• Carbamazepine and phenytoin induce 
cytochrome P450 enzymes
• Phenytoin – plasma protein bound
• Valproate inhibits the metabolism of 
phenobarbital, phenytoin, carbamazepine
and ethosuximide
INTERACTIONS BETWEEN 
ANTISEIZURE DRUGS 
With other antiepileptic Drugs:
- Carbamazepine with
phenytoin Increased metabolism of carbamazepine
phenobarbital Increased metabolism of epoxide.
- Phenytoin with
primidone Increased conversion to phenobarbital.
- Valproic acid with
clonazepam May precipitate nonconvulsive status 
epilepticus
phenobarbital Decrease metabolism, increase toxicity.
phenytoin Displacement from binding, increase toxicity.
ANTISEIZURE DRUG INTERACTIONS
With other drugs:
antibiotics phenytoin, phenobarb, carb.
anticoagulants phenytoin and phenobarb
met.
cimetidine displaces pheny, v.a. and BDZs
isoniazid toxicity of phenytoin
oral contraceptives antiepileptics metabolism.
salicylates displaces phenytoin and v.a. 
theophyline carb and phenytoin may
effect.
Side Effects
• Antiepileptic drugs frequently produce CNS 
and gastrointestinal side effects
• Some antiepileptic drugs infrequently cause 
severe hematologic or hepatic toxicity
• Valproate and phenytoin cause birth defects  
Management of Seizure Disorders
• Start therapy  with low dose of single drug
• Increase dose to attain serum concentration
• If single drug is not effective, a second drug 
may be added or substituted
• Discontinue drug use slowly
• Monitor serum levels to ensure adequate 
dosage (toxicity, therapeutic failure or non-
compliance)
Therapeutic choices
Seizure type 1st choice alternative or add-on
Tonic-clonic carbamazepine clobazam
phenytoin lamotrigine
valproic acid topiramate
Absence ethosuximide clobazam
valproic acid lamotrigine
topiramate
Partial (simple carbamazepine clobazam
or complex) phenytoin lamotrigine
valproic acid
phenobarbital


Pharmacokinetic Parameters
PHENYTOIN (Dilantin)
• Oldest nonsedative antiepileptic 
drug.
• Fosphenytoin, a more soluble 
prodrug is used for parenteral 
use.
• “Fetal hydantoin syndrome”
• It alters Na+, Ca2+ and K+ 
conductances.
• Inhibits high frequency 
repetitive firing.
• Alters membrane potentials.
• Alters a.a. concentration.
• Alters NTs (NE, ACh, GABA)
Toxicity:
•Ataxia and nystagmus.
•Cognitive impairment.
•Hirsutism
•Gingival hyperplasia.
•Coarsening of facial 
features.
•Dose-dependent zero order 
kinetics.
•Exacerbates absence 
seizures.
Fetal Hydantoin Syndrome
• Pre- and postnatal growth deficiency with 
psychomotor retardation, microcephaly with a ridged 
metopic suture, hypoplasia of the nails and finger-like 
thumb and hypoplasia of the distal phalanges. 
• Radiological skeletal abnormalities reflect the 
hypoplasia and fused metopic suture. 
• Cardiac defects and abnormal genitalia.
Teratogenicity of several anticonvulsant medications is 
associated with an elevated level of oxidative 
metabolites that are normally eliminated by the 
enzyme epoxide hydrolase.
CARBAMAZEPINE (Tegretol)
• Tricyclic, antidepressant (bipolar)
• 3-D conformation similar to 
phenytoin.
• Mechanism of action, similar to 
phenytoin. Inhibits high frequency 
repetitive firing.
• Decreases synaptic activity 
presynaptically.
• Binds to adenosine receptors (?).
• Inh. uptake and release of NE, but 
not GABA.
• Potentiates postsynaptic effects of 
GABA.
• Metabolite is active.
Toxicity:
•Autoinduction of 
metabolism.
•Nausea and visual 
disturbances.
•Granulocyte supression.
•Aplastic anemia.
•Exacerbates absence 
seizures.
OXCARBAZEPINE (Trileptal)
• Closely related to 
carbamazepine.
• With improved toxicity profile.
• Less potent  than 
carbamazepine.
• Active metabolite.
• Mechanism of action, similar 
to carbamazepine It alters Na+ 
conductance and inhibits high 
frequency repetitive firing.
Toxicity:
•Hyponatremia
•Less hypersensitivity
and induction of hepatic
enzymes than with carb.
PHENOBARBITAL (Luminal)
• Except for the bromides, it is the 
oldest antiepileptic drug.
• Although considered one of the safest 
drugs, it has sedative effects.
• Many consider them the drugs of 
choice for seizures only in infants.
• Acid-base balance important.
• Useful for partial, generalized tonic-
clonic seizures, and febrile seizures
• Prolongs opening of Cl- channels.
• Blocks excitatory GLU (AMPA) 
responses. Blocks Ca2+ currents (L,N).
• Inhibits high frequency, repetitive firing of 
neurons only at high concentrations.
•
Toxicity:
• Sedation.
• Cognitive 
impairment.
• Behavioral changes.
• Induction of liver 
enzymes.
• May worsen absence 
and atonic seizures.
PRIMIDONE (Mysolin)
• Metabolized to phenobarbital and 
phenylethylmalonamide (PEMA), 
both active metabolites.
• Effective against partial and 
generalized tonic-clonic seizures.
• Absorbed completely, low 
binding to plasma proteins.
• Should be started slowly to avoid 
sedation and GI problems.
• Its mechanism of action may be 
closer to phenytoin than the 
barbiturates.
Toxicity:
•Same as phenobarbital
•Sedation occurs early.
•Gastrointestinal complaints.
VALPROATE (Depakene)
• Fully ionized at body pH, thus 
active form is valproate ion.
• One of a series of carboxylic acids 
with antiepileptic activity. Its 
amides and esters are also active.
• Mechanism of action, similar to 
phenytoin. 
• ⇑ levels of GABA in brain.
• May facilitate Glutamic acid 
decarboxylase (GAD).
• Inhibits GAT-1. ⇓ [aspartate]Brain?
• May increase membrane potassium 
conductance.
Toxicity:
•Elevated liver enzymes 
including own.
•Nausea and vomiting.
•Abdominal pain and 
heartburn.
•Tremor, hair loss, 
•Weight gain.
•Idiosyncratic
hepatotoxicity.
•Negative interactions with 
other antiepileptics.
•Teratogen: spina bifida
ETHOSUXIMIDE (Zarontin)
• Drug of choice for absence seizures.
• High efficacy and safety.
• VD = TBW.
• Not plasma protein or fat binding
• Mechanism of action involves 
reducing low-threshold Ca2+ channel 
current (T-type channel) in thalamus.
At high concentrations:
• Inhibits Na+/K+ ATPase.
• Depresses cerebral metabolic rate.
• Inhibits GABA aminotransferase.
• Phensuximide = less effective
• Methsuximide = more toxic
Toxicity:
•Gastric distress, 
including, pain, nausea 
and vomiting
•Lethargy and fatigue
•Headache
•Hiccups
•Euphoria
•Skin rashes
•Lupus erythematosus (?)
CLONAZEPAM (Klonopin)
• A benzodiazepine.
• Long acting drug with efficacy 
for absence seizures.
• One of the most potent 
antiepileptic agents known.
• Also effective in some cases of 
myoclonic seizures.
• Has been tried in infantile 
spasms.
• Doses should start small. 
• Increases the frequency of  Cl-
channel opening.
Toxicity:
• Sedation is prominent. 
• Ataxia.
• Behavior disorders.
VIGABATRIN (γ-vinyl-GABA)
• Absorption is rapid, bioavailability 
is ~ 60%, T 1/2 6-8 hrs, eliminated 
by the kidneys. 
• Use for partial seizures and West’s 
syndrome.
• Contraindicated if preexisting 
mental illness is present.
• Irreversible inhibitor of GABA-
aminotransferase (enzyme 
responsible for metabolism of 
GABA) => Increases inhibitory 
effects of GABA.
• S(+) enantiomer is active.
Toxicity:
•Drowsiness
•Dizziness
•Weight gain
•Agitation
•Confusion
•Psychosis
LAMOTRIGINE (Lamictal) 
• Presently use as add-on therapy with 
valproic acid (v.a. conc. are be reduced).
• Almost completely absorbed
• T1/2 = 24 hrs
• Low plasma protein binding 
• Also effective in myoclonic and 
generalized seizures in childhood and 
absence attacks.
• Suppresses sustained rapid firing of 
neurons and produces a voltage and use-
dependent inactivation of sodium 
channels, thus its efficacy in partial 
seizures.
Toxicity:
•Dizziness
•Headache
•Diplopia
•Nausea
•Somnolence
•Rash
FELBAMATE  (Felbatrol)
• Effective against partial seizures 
but has severe side effects.
• Because of its severe side effects, 
it has been relegated to a third-line 
drug used only for refractory 
cases.
Toxicity:
•Aplastic anemia
•Severe hepatitis
TOPIRAMATE (Topamax)
• Rapidly absorbed, bioav. is > 
80%, has no active metabolites, 
excreted in urine.T1/2 = 20-30 hrs
• Blocks repetitive firing of 
cultured neurons, thus its 
mechanism may involve blocking 
of voltage-dependent sodium 
channels
• Potentiates inhibitory effects of 
GABA (acting at a site different 
from BDZs and BARBs).
• Depresses excitatory action of 
kainate on AMPA receptors.
• Teratogenic in animal models.
Toxicity:
• Somnolence
• Fatigue
• Dizziness
• Cognitive slowing
• Paresthesias
• Nervousness
• Confusion
• Urolithiasis
TIAGABINE (Gabatril)
• Derivative of nipecotic acid.
• 100% bioavailable, highly protein 
bound.
• T1/2 = 5 -8 hrs
• Effective against partial and 
generalized tonic-clonic seizures.
• GABA uptake inhibitor GAT-1.
Toxicity:
•Dizziness
•Nervousness
•Tremor
•Difficulty concentrating
•Depression
•Asthenia
•Emotional lability
•Psychosis
•Skin rash
ZONISAMIDE (Zonegran) 
• Sulfonamide derivative.
• Marketed in Japan.
• Good bioavailability, low pb.
• T1/2 = 1 - 3 days
• Effective against partial and 
generalized tonic-clonic 
seizures.
• Mechanism of action involves 
voltage and use-dependent 
inactivation of sodium channels 
(?).
• May also involve Ca2+ channels.
Toxicity:
•Drowsiness
•Cognitive 
impairment
•High incidence of 
renal stones (?).
GABAPENTIN (Neurontin)
• Used as an adjunct in partial and 
generalized tonic-clonic seizures.
• Does not induce liver enzymes.
• not bound to plasma proteins.
• drug-drug interactions are 
negligible.
• Low potency.
• An a.a.. Analog of GABA that 
does not act on GABA receptors, it 
may however alter its metabolism,  
non-synaptic release and transport.
Toxicity:
•Somnolence.
•Dizziness.
•Ataxia.
•Headache.
•Tremor.
